Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NRXP compared with CLLS: revenue, margins and what each company keeps, and the suppliers and customers both name
NRXP
NRX Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
CLLS
Cellectis S.A.
Change
Mkt cap
Revenue
Revenue
vs
Compare
NRXP
NRX Pharmaceuticals, Inc.
vs
CLLS
Cellectis S.A.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
NRXP
NRX Pharmaceuticals, Inc.
Change
2.39
▲
+5.26%
Mkt cap
$107.8M
Revenue
$6,000
Q2 FY26
CLLS
Cellectis S.A.
Change
1.03
▼
−12.25%
Regular session
Nov 6 '26
Mkt cap
$103.3M
Revenue
—
vs
Compare
Regular session
Nov 6 '26
NRXP
NRX Pharmaceuticals, Inc.
vs
CLLS
Cellectis S.A.
2.39
▲
+5.26%
Price
1.03
▼
−12.25%
$107.8M
Mkt cap
$103.3M
Q2 FY26
$6,000
Revenue
—
Change
Change
NRXP
2.39
▲
+5.26%
vs
CLLS
1.03
▼
−12.25%
Regular session
Nov 6 '26
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
NRXP, solid
CLLS, dashed